Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(13%)
Results Posted
25%(1 trials)

Phase Distribution

Ph not_applicable
1
13%
Ph phase_1
3
38%
Ph phase_3
1
13%
Ph phase_2
3
38%

Phase Distribution

3

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
3(37.5%)
Phase 2Efficacy & side effects
3(37.5%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(2)

Detailed Status

Completed4
unknown2
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (37.5%)
Phase 23 (37.5%)
Phase 31 (12.5%)
N/A1 (12.5%)

Trials by Status

recruiting113%
unknown225%
withdrawn113%
completed450%

Recent Activity

1 active trials
Showing 5 of 8
recruitingphase_2

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

NCT06382155
withdrawnphase_1

Dexamethasone/Pancreatic Clamp P&F

NCT06126354
unknownphase_1

Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF

NCT02179255
unknownphase_3

Treatment of GHD Associated With CHF

NCT03775993
completedphase_2

Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

NCT01947907
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06382155Phase 2

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

Recruiting
NCT06126354Phase 1

Dexamethasone/Pancreatic Clamp P&F

Withdrawn
NCT02179255Phase 1

Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF

Unknown
NCT03775993Phase 3

Treatment of GHD Associated With CHF

Unknown
NCT01947907Phase 2

Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

Completed
NCT01010425Phase 1

Pharmacokinetics and Pharmacodynamics of ACP-001 (TransCon PEG hGH)

Completed
NCT00512473Not Applicable

Growth Hormone Signaling in Vivo in Humans

Completed
NCT00300664Phase 2

A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8